Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 175 percent decrease over losses of $(0.04) per share from the same period last year.
Posted In: ACST